NASDAQ:RDHL

Redhill Biopharma Stock Predictions

Healthcare > Drug Manufacturers - Specialty & Generic

Buy RDHL

*Your capital is at risk

$1.00

-0.0100 (-0.99%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

RDHL Prediction Chart

RDHL Predictions History

Latest community submissions for RDHL.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
NameNotImportant Pro	May 6, 2019	$7.78 -99.90%	$8.11	X	95.93%
Warren.W.Kessler.24018	Apr 30, 2018	$4.94 -99.90%	$4.85	V	98.10%
michael.schanding.10551	Nov 6, 2017	$8.85 -99.89%	$8.30	V	93.40%
JS Pro	Nov 6, 2017	$8.82 -99.89%	$8.30	V	93.70%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RDHL with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT REDHILL BIOPHARMA LTD.

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development pr...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by